- Home
- LGND vs RUN Comparison
LGND vs RUN Comparison
Compare LGND & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- RUN
- Stock Information
- Founded
- LGND 1987
- RUN 2007
- Country
- LGND United States
- RUN United States
- Employees
- LGND N/A
- RUN N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- RUN Industrial Machinery/Components
- Sector
- LGND Health Care
- RUN Miscellaneous
- Exchange
- LGND Nasdaq
- RUN Nasdaq
- Market Cap
- LGND 2.3B
- RUN 2.3B
- IPO Year
- LGND 1992
- RUN 2015
- Fundamental
- Price
- LGND $120.43
- RUN $10.06
- Analyst Decision
- LGND Strong Buy
- RUN Buy
- Analyst Count
- LGND 6
- RUN 21
- Target Price
- LGND $145.00
- RUN $19.75
- AVG Volume (30 Days)
- LGND 107.6K
- RUN 7.4M
- Earning Date
- LGND 11-07-2024
- RUN 11-07-2024
- Dividend Yield
- LGND N/A
- RUN N/A
- EPS Growth
- LGND 160.46
- RUN N/A
- EPS
- LGND 2.47
- RUN N/A
- Revenue
- LGND $152,422,000.00
- RUN $2,035,817,000.00
- Revenue This Year
- LGND $26.86
- RUN N/A
- Revenue Next Year
- LGND $13.16
- RUN $13.94
- P/E Ratio
- LGND $48.80
- RUN N/A
- Revenue Growth
- LGND N/A
- RUN N/A
- 52 Week Low
- LGND $67.53
- RUN $9.23
- 52 Week High
- LGND $129.90
- RUN $22.26
- Technical
- Relative Strength Index (RSI)
- LGND 52.94
- RUN 38.26
- Support Level
- LGND $113.39
- RUN $9.86
- Resistance Level
- LGND $124.03
- RUN $11.74
- Average True Range (ATR)
- LGND 5.31
- RUN 0.60
- MACD
- LGND -0.50
- RUN 0.05
- Stochastic Oscillator
- LGND 48.65
- RUN 8.75
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed either by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.